The Danish pharmaceutical company Novo Nordisk have won European approval for their diabetes drug Victoza. The European Commission approved the drug for marketing across the European Union. The European Medicines Agency had already offered a positive opinion.
Novo Nordisk praised the decision as a milestone, reportedly commented: "The European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults."
The company will launch the drug throughout Britain, Denmark and Germany this summer. Victoza has previously been the subject of concerns over safety profile, with the Food and Drug Administration returning a split vote for approval in the US market.
Diabetes drug cleared for European market
Fri, 03 Jul 2009
Recommended links
Diabetes insuranceDiabetes forum
Diabetes chat
Diabetes donate
Experiment aims for diabetes therapy
Long-term influence of diabetes surgery
Drug companies race for share of diabetes market
Roche enters diabetes drug market
Diabetes market increasingly competitive
Fake diabetes testing strips on the market
Insulin for diabetics withdrawn from market
New Pfizer insulin inhaler hits the diabetes market
Free diabetes check up at the supermarket
Diabetes drug stays on the market
Lilly plans for Japan diabetes market
